Q: I’m looking into Hyliion Holdings (HYLN) as a potential long-term position, but I’m trying to better understand its growth prospects.
Given that the company is still pre-commercial and currently recognizes most revenue from R&D services rather than product sales, what’s your view on its path to commercialization and revenue growth? And are there particular risks or milestones you’d prioritize watching.
Given that the company is still pre-commercial and currently recognizes most revenue from R&D services rather than product sales, what’s your view on its path to commercialization and revenue growth? And are there particular risks or milestones you’d prioritize watching.
